Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers

NCT02619877 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot Ulcer

Interventions

BIOLOGICAL: ALLO-ASC-DFU
OTHER: Standard therapy

Sponsor

Anterogen Co., Ltd.